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ABSTRACT  
Background: Infectious gastroenteritis is a major risk factor to develop post-infectious 
irritable bowel syndrome (PI-IBS). It remains unknown why only a subgroup of infected 
individuals develops PI-IBS. We hypothesize that immunogenetic predisposition is an 
important risk factor. Hence, we studied the effect of Citrobacter rodentium-infection on 
visceral sensitivity in Th1-predominant C57BL/6 and Th2-predominant Balb/c mice. 
Methods: Eight weeks old mice were gavaged with Citrobacter rodentium, followed by 1 
hour of water-avoidance stress (WAS) at 5 weeks PI. At 10, 14 days and 5 weeks PI, samples 
were assessed for histology and inflammatory gene expression by RT-qPCR. Visceral 
sensitivity was evaluated by visceromotor-response-recordings (VMR) to colorectal-
distension.  
Key results: Citrobacter rodentium evoked a comparable colonic inflammatory response at 
14 days PI characterized by increased crypt length and upregulation of Th1/Th17 cytokine 
mRNA levels (puncorrected<0.05) in both C57BL/6 and Balb/c mice. At 5 weeks PI, 
inflammatory gene mRNA levels returned to baseline in both strains. The VMR was maximal 
at 14 days PI in C57BL/6 (150±47%;p=0.02) and Balb/c mice (243±52%;p=0.03). At 3 weeks 
PI, the VMR remained increased in Balb/c (176±23%; p=0.02), but returned to baseline in 
C57BL/6 mice. At 5 weeks PI, WAS could not re-introduce visceral hypersensitivity (VHS). 
Conclusions&Inferences: Citrobacter rodentium infection induces transient VHS in 
C57BL/6 and Balb/c mice, which is more pronounced and persisted one week longer in 
Balb/c mice, suggesting that a Th2 background may represent a risk factor for prolonged PI-
VHS. Although other strain-related differences may contribute, a Th2 background may 
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represent a risk factor for prolonged PI-VHS. As PI-VHS is only transient, other factors seem 
are crucial for persistent VHS development as observed in PI-IBS. 
Key words: Irritable Bowel Syndrome, visceral hypersensitivity, citrobacter rodentium  
KEY MESSAGES 
General statement: Visceral hypersensitivity (VHS) is a hallmark of (post-infectious) irritable 
bowel syndrome (PI-IBS) but the underlying mechanisms remain largely unknown.  
Aims/goals: We studied whether immunogenetic background and acute stress in the post-
Citrobacter rodentium infectious phase influence the development of VHS. 
Basic methodology: Visceral nociception was assessed by visceromotor-response-recordings 
(VMR) to colorectal distension. Colonic inflammation was evaluated by RT-qPCR and H&E 
staining.  
Summary: In the acute infectious phase, Citrobacter rodentium evoked maximal visceral pain 
perception in Th1 and Th2 predominant C57BL/6 and Balb/c mice respectively. Visceral 
nociception remained increased in Balb/c but not in C57BL/6 mice at 3 weeks PI. Five weeks 
PI, inflammation was completely resolved and VMR returned to normal in both strains. Acute 
water avoidance stress could not re-introduce VHS, regardless of the immunogenetic 
background.  
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INTRODUCTION 
Three to 31 % of individuals develop irritable bowel syndrome (IBS)
1
 following an infectious 
gastroenteritis
2-11
 and are referred to as post-infectious IBS patients (PI-IBS). Symptoms vary 
from patient to patient but typically include chronic abdominal pain, bloating and altered 
defecation patterns in the absence of an organic cause
12
. Visceral hypersensitivity, defined as 
increased sensitivity to visceral stimuli such as luminal distension, is one of the hallmarks of 
IBS
13
 and can persist for years after the initial infection
14
. Up to date, it is unknown why only 
a subgroup of infected individuals will develop PI-IBS.  
The risk to develop PI-IBS varies with the infectious agent
15-18
 with Campylobacter jejuni, 
Salmonella, Shigella and Escherichia coli as main pathogens. Human Escherichia coli colitis 
can be modeled by the Citrobacter rodentium murine model of self-limiting colitis, as C. 
rodentium shares 67% of its genes with the human enteropathogenic and enterohaemorrhagic 
E. coli
19, 20
. Based on these observations, C. rodentium infection may represent a potential 
model of PI-IBS. Previously, Ibeakanma C. et al. showed that C. rodentium infection in the 
Th1 predominant mouse strain C57BL/6 mice, evoked hyperexcitability of colonic dorsal root 
ganglia (DRG) neurons and increased afferent nerve firing that persisted until 30 days PI
21
. 
Stress concurrently with the infection enhanced neuronal excitability, while repeated water 
avoidance stress in the PI phase produced no greater enhancement than stress applied alone
21, 
22
, indicating that stress at the time of infection seems to increase the risk to develop post-
infectious visceral hypersensitivity.  
Microscopic inflammation has been well documented in PI-IBS and is believed to underlie PI-
IBS pathophysiology
2, 23-25
. Serial rectal biopsies taken from patients who developed IBS after 
Campylobacter jejuni gastroenteritis showed a persistent inflammatory infiltrate, with an 
increase in enterochromaffin cells and T lymphocyte cell counts
2
. Increased mast cell 
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numbers have been observed in PI-IBS
24
 and non PI-IBS
26
, showing significant correlations 
between IBS severity and mast cell counts, spontaneous mast cell tryptase release and colonic 
permeability
26
. Additional evidence includes upregulation of the pro-inflammatory cytokine 
interleukin-1β (IL-1β) in rectal biopsies of PI-IBS patients
27
, and increased pro-inflammatory 
cytokine release, f.e. TNF-α, IL-1β and IL-6, by peripheral blood mononuclear cells
28
. Based 
on the knowledge that mast cells play a key role in IBS and are classically involved in a Th2 
immune response, we speculate that the immunogenetic background of the host may be an 
important component dictating the nature of the immune response and the subsequent 
development of PI-IBS. 
To gain insight into the role of immunogenetic background as a risk to develop VHS after an 
infection, we assessed the course of infection and visceral sensitivity in C. rodentium infected 
Th1 predominant C57BL/6 and Th2 predominant Balb/c mice. Moreover, we assessed if 
stress in the PI phase can re-initiate visceral hypersensitivity. 
MATERIALS AND METHODS  
All experiments were conducted in accordance with the institutional guidelines and approved 
by the animal ethical committee of the KU Leuven (protocol numbers P179/2009 and 
P109/2010). 
Animals 
Six weeks old male C57BL/6 and Balb/c mice were purchased from Janvier (Saint-Berthevin 
Cedex, France) and left undisturbed for at least 1 week for acclimatization. Animals were 
maintained under a 14:10h dark/light cycle, at a temperature of 20-22 °C, provided with food 
and water ad libitum. 
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Citrobacter rodentium (C. rodentium) infection  
C. rodentium (DBS100, ATCC
®
 51459
™
, Teddington, United Kingdom) was cultured 
overnight in Luria-Bertani broth (LB) medium (MP Biomedicals, Drogenbos, Belgium) (37 
°C, 200 rpm). Fifteen hours later, the bacteria were centrifuged (4 °C, 2000 rpm, 10 minutes) 
and fresh LB medium was added to dissolve the pellet. Eight weeks old mice were infected by 
oral gavage of 3 x 10
10
 colony forming units C. rodentium or sterile 0.9 % NaCl (B. Braun 
Medical NV/SA, Diegem, Belgium) followed by intraperitoneal (i.p.) injection of 200 µl 
sterile 0.9 % NaCl to prevent dehydration
29, 30
. 
Water avoidance stress (WAS) model  
At 5 weeks post-infection, a bucket with a platform of 40 mm diameter was filled with fresh 
room temperature water (20 °C) up to 1 cm of the top of the platform. Mice were placed on 
the platform for 1 hour and the visceromotor response was measured 24 hours later
31
. 
Telemetric Visceromotor Response (VMR) recordings 
Mice of at least 20 grams were implanted with Physiotel ETA-F10 telemetric transmitters 
(Data Sciences International, MC s'Hertogenbosch, The Netherlands). Hereto, mice were 
anaesthetized by i.p. injection of 20 mg/kg ketamine (Nimatek, Eurovet Animal Health B.V., 
AE Bladel, The Netherlands) and 1 mg/kg xylazine (Rompun 2 %, Bayer, Diegem, Belgium) 
and placed on a heating pad (± 30 °C). The telemetric transmitter was inserted in the 
abdominal cavity, the electrodes were tunneled through the abdominal wall using a 18G 
needle (Terumo Europe n.v., Leuven, Belgium) and the non-insulated tips were sutured in 
parallel (± 5 mm apart) into the left external abdominal oblique muscle. After surgery, mice 
recovered for 12 hours on a heating pad where after they were left undisturbed for 10 
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consecutive days
32
. The radio telemetry experimental setup for measurement of the 
visceromotor response (VMR) to colorectal distension (CRD) in mice was adapted from
33, 34
.  
Colorectal distensions were performed to evoke abdominal cramping as read-out of visceral 
nociception. Hereto, a distension catheter (Fogarty catheter for arterial embolectomy, 4F; 
Edwards Lifesciences, Breda, The Netherlands) was inserted into the colon (3 cm from the 
rectum) of conscious, non-restraint, mice and distended with volumes progressively 
increasing from 20 µL to 80 µL, with each step lasting 10 sec and separated by 5 min non-
distension periods in-between
35
. The VMR responses were measured and quantified using 
Acknowledge 3.2.6 software (BIOPAC Systems Inc., Goleta, California, USA). For analysis, 
the mean value of the resting EMG signal 10 sec prior to distension (i.e. basal activity) was 
subtracted from the mean value of the electromyography signal evoked during the 10 sec 
distension. Data are presented as % VMR response ± SEM relative to maximum nociception 
response before infection (i.e. 80 µl distension is set at 100 %) or as area under the curve of 
the VMR responses. 
Evaluation of colonic inflammation by real-time quantitative polymerase chain reaction (RT-
qPCR) 
Total RNA was extracted from 30-50 mg intestinal tissue using the RNeasy Minikit (Qiagen 
GmBH, Hilden, Germany) according to the manufacturer’s instructions. cDNA of 2 µg total 
RNA was transcribed by the qScript cDNA supermix (Quanta Biosciences, Gaithersburg, 
Maryland, USA) according to manufacturers’ instructions.  
The primer sequences used to quantify inflammatory gene mRNA are listed in Table 1. Ten µl 
reaction mix per well was loaded onto a LightCycler® 480 multiwell plate 96 (Roche GmBH, 
Mannheim, Germany) containing 2.5 µl of each cDNA sample together with 5 µl FastStart 
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Essential DNA Green Master (Roche GmBH, Mannheim, Germany), 0.2 µl oligonucleotides 
(10 µM) and 2.3 µl RNase Free Water (Applied Biosystems, Halle, Belgium). Gene 
expression was normalized to an endogenous reference gene, β-actin. Relative gene 
expression was calculated as 2
-∆∆Ct
 
36
 and data are presented as relative expression ± standard 
error of the mean (SEM).  
Histopathology assessment  
At 10, 14 days and 5 weeks post-infection, full thickness intestinal tissue samples were 
freshly frozen in Tissue-Tek O.C.T.™ compound (Sakura Finetek Europe B.V., AV Alphen 
aan den Rijn, The Netherlands). Eight µm cryosections were cut and stained with 
heamatoxylin & eosin (H&E). Slides were reviewed using an Olympus BX41 light 
microscope (Aartselaar, Belgium) and scored blinded. H&E staining was performed to assess 
the degree of colitis using crypt length, crypt space and muscle thickness to address epithelial 
changes and overall mucosal architecture of each specimen
37
. All measurements were 
performed using Cell
F 
software (Aartselaar, Belgium). Mean crypt height was calculated from 
5-10 individual measurements of the lengths of all well oriented crypts on each specimen 
slide.  
Statistical analysis 
All statistical analyses were performed with Graphpad Prism software (GraphPad Software, 
San Diego, California, USA). Non-infected versus C. rodentium infected groups were 
compared by Unpaired t-test with Welch’s correction. Results are presented after Bonferroni 
correction for multiple testing (for RT-qPCR data based on 13 genes, puncorrected<0.004 was 
considered to be significant). VMR recordings were analyzed by 2-way ANOVA with 
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Bonferroni post-hoc correction. A p value < 0.05 was considered significant. Data are 
presented as mean + SEM. 
RESULTS  
C. rodentium infection evokes transient colonic inflammation in C57BL/6 and Balb/c mice  
All animals were monitored daily and the majority of animals (85–90%) exhibited signs of 
illness (e.g. decreased activity) for 2–3 days following infection but recovered quickly. None 
of the animals died. Infected C57BL/6 mice lost 5% of their initial body weight compared to 
2% in Balb/c mice within the first 4 days post-infection (PI). Up to 2 weeks PI, infected 
C57BL/6 (Fig. 1A) and Balb/c (Fig. 2A) did not reach the body weight of the non-infected 
controls. 
To identify potential differences in the degree of inflammation evoked by C. rodentium, 
inflammatory marker mRNA expression and histology were assessed in colon and small 
intestine at 10 and 14 days PI. Small intestinal IFN-γ, TNF-α and IL-1β mRNA expression 
was increased in C. rodentium infected C57BL/6 mice at 10 days PI but this increase was not 
significant after correction for multiple testing (Supplementary Fig. 1A). In contrast, MCP-1 
mRNA levels were significantly decreased (p unpaired t-test Welch’s correction = 0.0001) at 
10 days PI in the small intestine of infected Balb/c mice (Supplementary Fig. 1B).  
At 10 days PI, colonic c-kit mRNA expression was significantly decreased in infected 
C57BL/6 mice compared to non-infected controls (p unpaired t-test Welch’s correction = 
0.0037; Fig. 1B). MCP-1 and IL-10 mRNA expression was increased in infected C57BL/6 
mice, but did not remain significant after correction for multiple testing (Fig. 1B). At 14 days 
PI, there was a tendency towards increased IL-1β, IL-17 and IL-10 mRNA expression while c-
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kit mRNA expression was decreased in infected C57BL/6 mice, these results did not remain 
significant after correction for multiple testing (Fig. 1B). 
In contrast, infected Balb/c mice showed decreased colonic mRNA levels of MCP-1 and 
increased IL-10 mRNA expression compared to non-infected controls at 10 days PI (p 
unpaired t-test Welch’s correction < 0.004; Fig. 2B). IFN-ɣ, TNF-α, IL-1β and IL-17 mRNA 
were also upregulated, but could not withstand correction for multiple testing. At 14 days PI, 
TNF-α, IL-17 and IL-10 mRNA levels were increased (p unpaired t-test Welch’s correction 
<0.004, Fig. 2B). Of note, colonic mast cell tryptase a/b mRNA expression was increased at 
10 and 14 days PI in infected Balb/c mice, but could not withstand correction for multiple 
testing (Fig. 2B).   
Comparison of colonic inflammatory gene expression between infected C57BL/6 and Balb/c 
mice in the acute inflammatory phase revealed only increased tryptase a/b levels in Balb/c 
mice (unpaired t-test Welch’s correction p = 0.004) (Supplementary Fig. 2) and a tendency for 
increased IL-17 mRNA and decreased IL-6 in Balb/c mice, but this could not withstand 
correction for multiple testing. At 5 weeks PI, IFN-ɣ and IL-10 mRNA levels were 
significantly lower in infected Balb/c compared to infected C57BL/6 mice (Supplementary 
Fig. 2).  
H&E staining was performed to assess the degree of colitis using crypt length, crypt space 
and muscle thickness to address epithelial changes and overall mucosal architecture. 
Histology of the colon at 10 days PI shows signs of colitis as reflected by increased crypt 
length in both infected C57BL/6 (Fig. 3A) and Balb/c (Fig. 3B) mice compared to non-
infected controls (p unpaired t-test Welch’s correction = 0.029 and p <0.0001, respectively), 
an effect that was more pronounced at PI day 14 (Fig. 3A, B). No changes in muscle thickness 
or space between the crypts were observed between non-infected and infected mice, 
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irrespective of genetic immune background (data not shown). Based on the inflammatory cell 
infiltrate in mucosa and submucosa, mild hyperplasia and minimal goblet cell loss, we can 
conclude that C. rodentium induces a mild colonic inflammation in both mouse strains. 
At 5 weeks PI, in the absence of histological changes (Fig. 3A, B), infected C57BL/6 but not 
Balb/c mice still showed a tendency, albeit not statistically significant after multiple testing 
correction, towards increased colonic inflammatory mRNA expression of IL-1β, IL-6, IFN-γ 
and IL-17 compared to non-infected controls (Fig. 2B).  
Taken together, C. rodentium evokes a transient mild inflammatory response characterized by 
upregulation of inflammatory cytokine mRNA in both mouse strains at 10 and 14 days PI, 
with pronounced IL-17 mRNA upregulation.  
C. rodentium infection induces transient VHS in C57BL/6 and Balb/c mice  
Colorectal sensitivity was assessed by VMR at 2, 3 and 4 weeks PI and 24 hours post-WAS at 
5 weeks PI. At 2 weeks PI, in the presence of colonic inflammation, visceral sensitivity was 
significantly increased compared to baseline in both infected C57BL/6 (Fig. 4A) and Balb/c 
(Fig. 4B) mice. The response to colorectal distension (increase in visceral nociception at the 
maximum distension volume compared to pre-infection) was increased by 50 + 16% in 
C57BL/6 (p 2-wayANOVA=0.02) and by 143 + 31% in Balb/c (p 2-wayANOVA=0.03) 
mice. At 3 weeks PI, visceral sensitivity to colorectal distension returned to baseline levels in 
C57BL/6 mice, while the VMR response to colorectal distension was still significantly 
increased by 76 + 14% in Balb/c mice (p 2-wayANOVA=0.02). Only Balb/c mice with the 
highest VMR response at 2 weeks PI remained, to a lower extent, hypersensitive at 3 weeks 
PI (Supplementary Fig. 3). Visceral sensitivity normalized at 4 weeks PI in both mouse strains 
(Fig 4 A-D). 
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As stress may exacerbate or re-initiate visceral sensitivity
22, 38, 39
, we next assessed the effect 
of acute water avoidance stress (WAS) on post-infectious visceral sensitivity. One hour of 
WAS did not re-install VHS at 5 weeks PI (Fig. 4A-D). Visceral sensitivity to colorectal 
distension was similar to that before the infection, for both mouse strains (Fig. 4A-D).  
DISCUSSION 
In humans, it remains unclear why only a subgroup of infected individuals develops long-term 
PI-IBS. Based on the importance of mast cells in IBS symptom generation
25, 40-42
, we 
hypothesized that a Th2 immune background may increase the risk to develop PI-IBS and 
used Citrobacter rodentium as a murine model to study our hypothesis. In the present study, 
we evaluated the role of C. rodentium-induced inflammation and acute stress on visceral 
sensory function in Th1-predominant C57BL/6 and Th2-predominant Balb/c mice. C. 
rodentium induced a self-limiting colitis in both strains with induction of colonic 
inflammation and increased visceral sensitivity to colorectal distension at 2 weeks post-
infection. The increase in visceral nociception was transient and lasted 1 week longer in the 
Th2-predominant Balb/c mice. An episode of acute water avoidance stress (WAS) did not re-
initiate PI-VHS irrespective of the immunogenetic background. These results suggest that a 
Th2-predominant immunogenetic background may represent one of the risk factors to develop 
prolonged abnormal visceral nociception following an episode of infectious gastroenteritis. 
This VHS is however transient, suggesting that other factors or triggers, resulting in a 
sustained abnormal pain response as observed in PI-IBS patients, must be involved. Of note, 
other strain-related factors, such as differences in nociception and behavior, may undoubtedly 
contribute as well.  
In mice, C. rodentium is known to induce an acute, self-limiting colitis, histologically 
associated with crypt hyperplasia and goblet cell depletion
43, 44
. The infection serves as a 
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model for human infectious gastroenteritis induced by enteropathogenic Escherichia coli, a 
well-known trigger for PI-IBS in humans
45
. Upon infection, C. rodentium transiently 
colonizes the distal colon with a peak of infection around 10 – 14 days PI in both C57BL/6
21
 
and Balb/c mice
46
. In line, we showed that C. rodentium induced a transient colonic 
inflammation, characterized by increased cytokine mRNA levels, irrespective of the genetic 
background, with overt inflammation at 14 days post-infection. The more pronounced colonic 
expression of IFN-ɣ/IL-17, identified as crucial players for host defense against infection
47
 at 
day 14 PI indicates that the peak of infection for both Th1 and Th2 predominant mice lays 
around 14 days post-infection. Inflammatory cytokine mRNA expression was however not 
significantly different between the two mouse strains, except for increased tryptase a/b 
mRNA levels in infected Balb/c mice compared to infected C57BL/6 mice. The peak of 
infection/inflammation was associated with an increase in visceral nociception to colorectal 
distension in both strains at 2 weeks PI. The duration of increased nociception differed 
however, i.e. Balb/c mice showed increased VMR responses to colorectal distension up to 3 
weeks PI (76% increase) while visceral perception of C57BL/6 mice was already normalized.  
Of interest, we noticed that mainly mice with a very high VMR response at 2 weeks PI (in 
particular Balb/c mice) remained VHS at 3 weeks PI (Supplementary Fig. 3), indicating that 
the magnitude of the VMR response at 2 weeks PI may be associated with a slower recovery 
and increased duration of the aberrant nociceptive response. One potential explanation may be 
the difference in immunogenetic background leading to more pronounced mast cell activation 
in the Th2 prone Balb/c mice, as suggested by increased tryptase a/b mRNA expression in the 
acute infectious phase in Balb/c mice compared to infected C57BL/6 mice. However, the 
degree of upregulation was relatively small questioning its physiological relevance. 
Moreover, Th2-associated cytokine expression did not differ between C. rodentium infected 
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C57BL/6 and Balb/c mice, suggesting that other factors contribute to the prolonged VHS 
observed in infected Balb/c mice. In fact, there are indeed documented strain differences with 
respect to behavioral
48, 49
 and nociceptive tests
50, 51
, most likely contributing to the prolonged 
VHS in Balb/c mice. It should also be emphasized though that the VHS observed in both 
strains completely normalized during the PI phase (i.e. at 4 weeks PI), while patients with PI-
IBS continue to have symptoms for several years following the infectious episode. These 
findings are in accordance with other studies, showing no increased VMR response in 
C57BL/6 mice 30 days PI
22
. Hence, other mechanisms may be critical for the development of 
chronic VHS. 
Psychological comorbidities such as stress, anxiety, depression and adverse early-life events 
are known to induce and/or exacerbate IBS symptoms
52-57
. Previously, van den Wijngaard et 
al.
58
 showed long-lasting VHS in response to an episode of acute stress, induced by water-
avoidance stress (WAS), in a rat model of maternal separation
58, 59
. Therefore, we evaluated if 
a previous gastrointestinal infection would increase the risk to develop VHS in response to 
WAS. In the present study however, acute WAS at 5 weeks PI did not recreate VHS, 
irrespective of genetic background. Our data therefore seem to indicate that stress applied 
after an intestinal infection is not a major trigger to develop long-lasting VHS. Indeed, 
Spreadbury et al.
60
 showed that chronic psychological stress after clearance of the infection 
did not have an additional effect on neuronal excitability compared to non-infected mice 
exposed to the same stressor
60
. Nevertheless, these data confirm that the bacterial infection 
per se does not alter visceral perception. It should be stressed though that psychological co-
morbidity prior to and not after clearance of the infection is associated with an increased risk 
to develop IBS
22, 60, 61
. In line, stress during or before C. rodentium infection results in an 
exaggerated peripheral nociceptive signaling compared to C. rodentium alone
22
 and to 
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enhanced excitability of dorsal root ganglion neurons compared to non-infected controls
60
. 
Altogether, these data highlight the importance of the timing of stress relative to the infection. 
This was indeed further corroborated by our recent study showing that psychological 
comorbidity prior to or during a gastrointestinal infection predisposes individuals to develop 
IBS. Of note, we showed that the type of immune response raised against the infection is 
associated with the risk to develop IBS. Patients who developed a Th2-predominant cytokine 
profile at the time of infection had an increased risk of PI-IBS 1 year later
62
. These data 
together with our current findings seem to support the hypothesis that the immunogenetic 
background may, at least to some extent, contribute to the risk to develop PI-IBS. 
Nevertheless, the duration of VHS in our murine PI model is rather short lasting, so clearly 
other factors must be involved.  
Of interest, recent evidence suggests that food allergens may be involved in IBS. Not only do 
more than 60% of patients with IBS report the onset or worsening of symptoms after meals
63
, 
submucosal instillation of food antigens in the duodenum was recently shown to evoke a local 
reaction with an instant influx of inflammatory cells and increased secretion
64
. Although the 
exact mechanism underlying these phenomena remains to be determined, one may speculate 
that an aberrant immune response to food antigens could be involved. Currently, we are 
investigating the hypothesis that prolonged VHS following a gastrointestinal infection may 
result from recurrent mast cell activation due to an aberrant immune response mounted 
against harmless intraluminal antigens present at the time of infection. If true, VHS will only 
develop upon re-exposure to these innocent bystander antigens, possibly explaining why no 
persistent VHS is observed in our current study. Preliminary data seem to support this 
hypothesis
65, 66
, but further experiments are clearly required.  
In summary, our study shows that C. rodentium infection induces a transient VHS in 
C57BL/6 and Balb/c mice, that is more pronounced and prolonged in Th2-predominant Balb/c 
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mice, indicating that a Th2 immune background may increase the susceptibility to develop PI-
IBS. Although other strain-related differences, such as differences in nociception and 
behavior, may contribute, our data suggest that a Th2 background may represent an additional 
risk factor for prolonged PI-VHS. It should be emphasized though that PI-VHS was transient 
and thus other factors must be involved in the persistent VHS as observed in patients with PI-
IBS. An acute episode of stress in the post-infectious phase could not re-introduce VHS 
indicating that other mechanisms leading to persistent VHS, as observed in patients, must be 
involved. 
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TABLES  
Table 1 | Primer sequences for gene mRNA quantification by RT-qPCR.  
Gene Protein Forward primer (5’ -> 3’) Reverse primer (3’ –> 5’) 
Actb β-actin CATTGCTGACAGGATGCAGAA GCTGATCCACATCTGCTGGAA 
Il1b IL-1β GGGCCTCAAAGGAAAGAATC TACCAGTTGGGGAACTCTGC 
Il4 IL-4 AAGAACACCACAGAGAGTGAGCTC TTTCAGTGATGTGGACTTGGACTC 
Il6 IL-6 AAGTCGGAGGCTTAATTACACATGT CCATTGCACAACTCTTTTCTCATTC 
Il10 IL-10 AGAAGCATGGCCCTGAAATCAAGG CTTGTAGACACCTTGGTCTTGGAG 
Il13 IL-13 CACGGCCCCTTCTAATGAGG CCTCTCCCCAGCAAAGTCTG 
Il17 IL-17 ACCTCACACGAGGCACAAGT AGCAGCAACAGCATCAGAGA 
Ifng IFN-γ GCCATCAGCAACAACATAAGCGTC CCACTCGGATGAGCTCATTGAATG 
Tnf TNF-α CCCCAAAGGGATGAGAAGTT CACTTGGTGGTTTGCTACGA 
Ccl2 MCP-1 CCCCACTCACCTGCTGCTACT GGCATCACAGTCCGAGTCACA 
Kit c-kit TGGGAGCTCTTCTCCTTAGGAA TGCTCCGGGCTGACCAT 
Tpsb2 Tryptase β 2 GCAGCTAAGATGCTGAAGCG CCTCATGTCCTCCCACGATG 
Tpsab1 Tryptase α/β 1 TTGCTGACCCCAACAAGGTC GGACGATGTAGAAGTCGGGG 
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FIGURE LEGENDS 
Figure 1 | Effect of Citrobacter rodentium infection on body weight and inflammatory 
gene expression of infected C57BL/6 mice. A, Body weight change during 5 weeks 
following infection in C57BL/6 mice. Data are presented as mean ± SEM. 2-way ANOVA 
Bonferroni correction, * p < 0.05. B, Scatter plots of colonic inflammatory gene mRNA 
expression relative to β-actin in non-infected (non-inf, at 14d post-vehicle) and C. rodentium 
infected C57BL/6 mice at 10 days, 14 days PI and 5 weeks PI. n = 6 – 7 mice/group, unpaired 
t-test Welch’s correction, ** p < 0.004. The horizontal lines represent the mean ± SEM. d = 
day, IL = interleukin, IFN = interferon, MCP1 = monocyte chemotactic protein 1, non-inf = 
non-infected, PI = post-infection, TNF = tumor necrosis factor, w = week. 
 
Figure 2 | Effect of Citrobacter rodentium infection on body weight and inflammatory 
gene expression of infected Balb/c mice. A, Body weight change during 5 weeks following 
infection in Balb/c mice. Data are presented as m an ± SEM. 2-way ANOVA Bonferroni 
correction, * p < 0.05, ** p < 0.01. B, Scatter plots of colonic inflammatory gene mRNA 
expression relative to β-actin in non-infected (non-inf, at 14d post-vehicle) and C. rodentium 
infected Balb/c mice at 10 days, 14 days PI and 5 weeks PI. n = 6 – 7 mice/group, unpaired t-
test Welch’s correction, ** p < 0.004, *** p < 0.001. The horizontal lines represent the mean 
± SEM. d = day, IL = interleukin, IFN = interferon, MCP1 = monocyte chemotactic protein 1, 
non-inf = non-infected, PI = post-infection, TNF = tumor necrosis factor, w = week. 
 
Figure 3 | Acute C. rodentium infection induces mild colonic inflammation in both 
C57BL/6 and Balb/c mice. H&E staining showing colonic sections at 10x enlargement in 
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non-infected and C. rodentium infected C57BL/6 (A) and Balb/c (B) mice with associated 
crypt length measurements at day 10 PI, day 14 PI and at 5 weeks PI.  n = 4 – 7 mice/group. p 
unpaired t-test Welch’s correction as indicated. The horizontal lines represent the mean ± 
SEM. 
 
Figure 4 | Acute C. rodentium infection triggers transient VHS in both C57BL/6 and 
Balb/c mice that is not restored by acute water avoidance stress in the post-infectious 
phase. A-B Upper panel: VMR recordings in C57BL/6 (A) and Balb/c (B) mice measured 
before infection (pre-infection, black dotted line) and at 2 (blue full line) and 3 (orange full 
line) weeks PI. A-B Lower panel: VMR recordings measured at 4 weeks PI (grey full line) 
and at 5 (green full line) weeks PI following WAS.  n = 4 – 7 mice/group, 2-way ANOVA 
with Bonferroni correction, * p < 0.05, ** p < 0.01. Data are presented as mean + SEM.  
AUC of VMR responses measured throughout the whole experiment in C. rodentium infected 
C57BL/6 (C) and Balb/c (D) mice. The black horizontal lines represent the 95% percentile of 
the AUC of C. rodentium infected C57BL/6 and Balb/c mice measured prior to C. rodentium 
infection. Data are presented as mean ± SEM. p paired t-test, as indicated. AUC = area under 
the curve, hr = hour, PI = post-infection, pre-inf = pre-infection, VMR = visceromotor 
response, WAS = water avoidance stress, w = week. 
 
SUPPLEMENTARY FIGURES (for online publication only) 
Supplementary Fig. 1 | Acute C. rodentium infection induces subtle changes in 
inflammatory gene mRNA expression in the small intestine of C57BL/6 at 10 days post-
infection. Scatter plots of small intestinal inflammatory gene mRNA expression relative to β-
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actin in C57BL/6 (A) and Balb/c (B) mice at 10 days and 14 days PI. n = 6 – 7 mice/group, 
unpaired t-test Welch’s correction, *** p < 0.001. The horizontal lines represent the mean ± 
SEM. d = day, IL = interleukin, IFN = interferon, MCP1 = monocyte chemotactic protein 1, 
PI = post-infection, TNF = tumor necrosis factor. 
 
Supplementary Fig. 2 | Comparison of colonic inflammatory gene mRNA expression 
between C. rodentium infected C57BL/6 and Balb/c mice. Scatter plots of colonic 
inflammatory mRNA expression in non-infected and C. rodentium infected C57BL/6 and 
Balb/c mice at different time points (as indicated). n = 6 – 7 mice/group, unpaired t-test 
Welch’s correction, ** p < 0.004, *** p < 0.001. The horizontal lines represent the mean ± 
SEM. BL/6 = C57BL/6, d = day, IL = interleukin, IFN = interferon, MCP1 = monocyte 
chemotactic protein 1, non-inf = non-infected, w = week. 
 
Supplementary Fig. 3 | Maximum VMR response at 2 weeks post-infection correlates 
with duration of hypersensitivity. Individual data showing the AUC of VMR responses 
from C. rodentium infected C57BL/6 and Balb/c mice (as indicated) measured up to 4 weeks 
post-infection. n = 5 - 7 mice/group.  
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ABSTRACT  
Background: Infectious gastroenteritis is a major risk factor to develop post-infectious 
irritable bowel syndrome (PI-IBS). It remains unknown why only a subgroup of infected 
individuals develops PI-IBS. We hypothesize that immunogenetic predisposition is an 
important risk factor. Hence, we studied the effect of Citrobacter rodentium-infection on 
visceral sensitivity in Th1-predominant C57BL/6 and Th2-predominant Balb/c mice. 
Methods: Eight weeks old mice were gavaged with Citrobacter rodentium, followed by 1 
hour of water-avoidance stress (WAS) at 5 weeks PI. At 10, 14 days and 5 weeks PI, samples 
were assessed for histology and inflammatory gene expression by RT-qPCR. Visceral 
sensitivity was evaluated by visceromotor-response-recordings (VMR) to colorectal-
distension.  
Key results: Citrobacter rodentium evoked a comparable colonic inflammatory response at 
14 days PI characterized by increased crypt length and upregulation of Th1/Th17 cytokine 
mRNA levels (puncorrected<0.05) in both C57BL/6 and Balb/c mice. At 5 weeks PI, 
inflammatory gene mRNA levels returned to baseline in both strains. The VMR was maximal 
at 14 days PI in C57BL/6 (150±47%;p=0.02) and Balb/c mice (243±52%;p=0.03). At 3 weeks 
PI, the VMR remained increased in Balb/c (176±23%; p=0.02), but returned to baseline in 
C57BL/6 mice. At 5 weeks PI, WAS could not re-introduce visceral hypersensitivity (VHS). 
Conclusions&Inferences: Citrobacter rodentium infection induces transient VHS in 
C57BL/6 and Balb/c mice, which persisted one week longer in Balb/c mice. Although other 
strain-related differences may contribute, a Th2 background may represent a risk factor for 
prolonged PI-VHS. As PI-VHS is transient, other factors are crucial for persistent VHS 
development as observed in PI-IBS. 
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Key words: Irritable Bowel Syndrome, visceral hypersensitivity, citrobacter rodentium  
KEY MESSAGES 
General statement: Visceral hypersensitivity (VHS) is a hallmark of (post-infectious) irritable 
bowel syndrome (PI-IBS) but the underlying mechanisms remain largely unknown.  
Aims/goals: We studied whether immunogenetic background and acute stress in the post-
Citrobacter rodentium infectious phase influence the development of VHS. 
Basic methodology: Visceral nociception was assessed by visceromotor-response-recordings 
(VMR) to colorectal distension. Colonic inflammation was evaluated by RT-qPCR and H&E 
staining.  
Summary: In the acute infectious phase, Citrobacter rodentium evoked maximal visceral pain 
perception in Th1 and Th2 predominant C57BL/6 and Balb/c mice respectively. Visceral 
nociception remained increased in Balb/c but not in C57BL/6 mice at 3 weeks PI. Five weeks 
PI, inflammation was completely resolved and VMR returned to normal in both strains. Acute 
water avoidance stress could not re-introduce VHS, regardless of the immunogenetic 
background.  
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INTRODUCTION 
Three to 31 % of individuals develop irritable bowel syndrome (IBS)
1
 following an infectious 
gastroenteritis
2-11
 and are referred to as post-infectious IBS patients (PI-IBS). Symptoms vary 
from patient to patient but typically include chronic abdominal pain, bloating and altered 
defecation patterns in the absence of an organic cause
12
. Visceral hypersensitivity, defined as 
increased sensitivity to visceral stimuli such as luminal distension, is one of the hallmarks of 
IBS
13
 and can persist for years after the initial infection
14
. Up to date, it is unknown why only 
a subgroup of infected individuals will develop PI-IBS.  
The risk to develop PI-IBS varies with the infectious agent
15-18
 with Campylobacter jejuni, 
Salmonella, Shigella and Escherichia coli as main pathogens. Human Escherichia coli colitis 
can be modeled by the Citrobacter rodentium murine model of self-limiting colitis, as C. 
rodentium shares 67% of its genes with the human enteropathogenic and enterohaemorrhagic 
E. coli
19, 20
. Based on these observations, C. rodentium infection may represent a potential 
model of PI-IBS. Previously, Ibeakanma C. et al. showed that C. rodentium infection in the 
Th1 predominant mouse strain C57BL/6 mice, evoked hyperexcitability of colonic dorsal root 
ganglia (DRG) neurons and increased afferent nerve firing that persisted until 30 days PI
21
. 
Stress concurrently with the infection enhanced neuronal excitability, while repeated water 
avoidance stress in the PI phase produced no greater enhancement than stress applied alone
21, 
22
, indicating that stress at the time of infection seems to increase the risk to develop post-
infectious visceral hypersensitivity.  
Microscopic inflammation has been well documented in PI-IBS and is believed to underlie PI-
IBS pathophysiology
2, 23-25
. Serial rectal biopsies taken from patients who developed IBS after 
Campylobacter jejuni gastroenteritis showed a persistent inflammatory infiltrate, with an 
increase in enterochromaffin cells and T lymphocyte cell counts
2
. Increased mast cell 
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numbers have been observed in PI-IBS
24
 and non PI-IBS
26
, showing significant correlations 
between IBS severity and mast cell counts, spontaneous mast cell tryptase release and colonic 
permeability
26
. Additional evidence includes upregulation of the pro-inflammatory cytokine 
interleukin-1β (IL-1β) in rectal biopsies of PI-IBS patients
27
, and increased pro-inflammatory 
cytokine release, f.e. TNF-α, IL-1β and IL-6, by peripheral blood mononuclear cells
28
. Based 
on the knowledge that mast cells play a key role in IBS and are classically involved in a Th2 
immune response, we speculate that the immunogenetic background of the host may be an 
important component dictating the nature of the immune response and the subsequent 
development of PI-IBS. 
To gain insight into the role of immunogenetic background as a risk to develop VHS after an 
infection, we assessed the course of infection and visceral sensitivity in C. rodentium infected 
Th1 predominant C57BL/6 and Th2 predominant Balb/c mice. Moreover, we assessed if 
stress in the PI phase can re-initiate visceral hypersensitivity. 
MATERIALS AND METHODS  
All experiments were conducted in accordance with the institutional guidelines and approved 
by the animal ethical committee of the KU Leuven (protocol numbers P179/2009 and 
P109/2010). 
Animals 
Six weeks old male C57BL/6 and Balb/c mice were purchased from Janvier (Saint-Berthevin 
Cedex, France) and left undisturbed for at least 1 week for acclimatization. Animals were 
maintained under a 14:10h dark/light cycle, at a temperature of 20-22 °C, provided with food 
and water ad libitum. 
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Citrobacter rodentium (C. rodentium) infection  
C. rodentium (DBS100, ATCC
®
 51459
™
, Teddington, United Kingdom) was cultured 
overnight in Luria-Bertani broth (LB) medium (MP Biomedicals, Drogenbos, Belgium) (37 
°C, 200 rpm). Fifteen hours later, the bacteria were centrifuged (4 °C, 2000 rpm, 10 minutes) 
and fresh LB medium was added to dissolve the pellet. Eight weeks old mice were infected by 
oral gavage of 3 x 10
10
 colony forming units C. rodentium or sterile 0.9 % NaCl (B. Braun 
Medical NV/SA, Diegem, Belgium) followed by intraperitoneal (i.p.) injection of 200 µl 
sterile 0.9 % NaCl to prevent dehydration
29, 30
. 
Water avoidance stress (WAS) model  
At 5 weeks post-infection, a bucket with a platform of 40 mm diameter was filled with fresh 
room temperature water (20 °C) up to 1 cm of the top of the platform. Mice were placed on 
the platform for 1 hour and the visceromotor response was measured 24 hours later
31
. 
Telemetric Visceromotor Response (VMR) recordings 
Mice of at least 20 grams were implanted with Physiotel ETA-F10 telemetric transmitters 
(Data Sciences International, MC s'Hertogenbosch, The Netherlands). Hereto, mice were 
anaesthetized by i.p. injection of 20 mg/kg ketamine (Nimatek, Eurovet Animal Health B.V., 
AE Bladel, The Netherlands) and 1 mg/kg xylazine (Rompun 2 %, Bayer, Diegem, Belgium) 
and placed on a heating pad (± 30 °C). The telemetric transmitter was inserted in the 
abdominal cavity, the electrodes were tunneled through the abdominal wall using a 18G 
needle (Terumo Europe n.v., Leuven, Belgium) and the non-insulated tips were sutured in 
parallel (± 5 mm apart) into the left external abdominal oblique muscle. After surgery, mice 
recovered for 12 hours on a heating pad where after they were left undisturbed for 10 
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consecutive days
32
. The radio telemetry experimental setup for measurement of the 
visceromotor response (VMR) to colorectal distension (CRD) in mice was adapted from
33, 34
.  
Colorectal distensions were performed to evoke abdominal cramping as read-out of visceral 
nociception. Hereto, a distension catheter (Fogarty catheter for arterial embolectomy, 4F; 
Edwards Lifesciences, Breda, The Netherlands) was inserted into the colon (3 cm from the 
rectum) of conscious, non-restraint, mice and distended with volumes progressively 
increasing from 20 µL to 80 µL, with each step lasting 10 sec and separated by 5 min non-
distension periods in-between
35
. The VMR responses were measured and quantified using 
Acknowledge 3.2.6 software (BIOPAC Systems Inc., Goleta, California, USA). For analysis, 
the mean value of the resting EMG signal 10 sec prior to distension (i.e. basal activity) was 
subtracted from the mean value of the electromyography signal evoked during the 10 sec 
distension. Data are presented as % VMR response ± SEM relative to maximum nociception 
response before infection (i.e. 80 µl distension is set at 100 %) or as area under the curve of 
the VMR responses. 
Evaluation of colonic inflammation by real-time quantitative polymerase chain reaction (RT-
qPCR) 
Total RNA was extracted from 30-50 mg intestinal tissue using the RNeasy Minikit (Qiagen 
GmBH, Hilden, Germany) according to the manufacturer’s instructions. cDNA of 2 µg total 
RNA was transcribed by the qScript cDNA supermix (Quanta Biosciences, Gaithersburg, 
Maryland, USA) according to manufacturers’ instructions.  
The primer sequences used to quantify inflammatory gene mRNA are listed in Table 1. Ten µl 
reaction mix per well was loaded onto a LightCycler® 480 multiwell plate 96 (Roche GmBH, 
Mannheim, Germany) containing 2.5 µl of each cDNA sample together with 5 µl FastStart 
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Essential DNA Green Master (Roche GmBH, Mannheim, Germany), 0.2 µl oligonucleotides 
(10 µM) and 2.3 µl RNase Free Water (Applied Biosystems, Halle, Belgium). Gene 
expression was normalized to an endogenous reference gene, β-actin. Relative gene 
expression was calculated as 2
-∆∆Ct
 
36
 and data are presented as relative expression ± standard 
error of the mean (SEM).  
Histopathology assessment  
At 10, 14 days and 5 weeks post-infection, full thickness intestinal tissue samples were 
freshly frozen in Tissue-Tek O.C.T.™ compound (Sakura Finetek Europe B.V., AV Alphen 
aan den Rijn, The Netherlands). Eight µm cryosections were cut and stained with 
heamatoxylin & eosin (H&E). Slides were reviewed using an Olympus BX41 light 
microscope (Aartselaar, Belgium) and scored blinded. H&E staining was performed to assess 
the degree of colitis using crypt length, crypt space and muscle thickness to address epithelial 
changes and overall mucosal architecture of each specimen
37
. All measurements were 
performed using Cell
F 
software (Aartselaar, Belgium). Mean crypt height was calculated from 
5-10 individual measurements of the lengths of all well oriented crypts on each specimen 
slide.  
Statistical analysis 
All statistical analyses were performed with Graphpad Prism software (GraphPad Software, 
San Diego, California, USA). Non-infected versus C. rodentium infected groups were 
compared by Unpaired t-test with Welch’s correction. Results are presented after Bonferroni 
correction for multiple testing (for RT-qPCR data based on 13 genes, puncorrected<0.004 was 
considered to be significant). VMR recordings were analyzed by 2-way ANOVA with 
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Bonferroni post-hoc correction. A p value < 0.05 was considered significant. Data are 
presented as mean + SEM. 
RESULTS  
C. rodentium infection evokes transient colonic inflammation in C57BL/6 and Balb/c mice  
All animals were monitored daily and the majority of animals (85–90%) exhibited signs of 
illness (e.g. decreased activity) for 2–3 days following infection but recovered quickly. None 
of the animals died. Infected C57BL/6 mice lost 5% of their initial body weight compared to 
2% in Balb/c mice within the first 4 days post-infection (PI). Up to 2 weeks PI, infected 
C57BL/6 (Fig. 1A) and Balb/c (Fig. 2A) did not reach the body weight of the non-infected 
controls. 
To identify potential differences in the degree of inflammation evoked by C. rodentium, 
inflammatory marker mRNA expression and histology were assessed in colon and small 
intestine at 10 and 14 days PI. Small intestinal IFN-γ, TNF-α and IL-1β mRNA expression 
was increased in C. rodentium infected C57BL/6 mice at 10 days PI but this increase was not 
significant after correction for multiple testing (Supplementary Fig. 1A). In contrast, MCP-1 
mRNA levels were significantly decreased (p unpaired t-test Welch’s correction = 0.0001) at 
10 days PI in the small intestine of infected Balb/c mice (Supplementary Fig. 1B).  
At 10 days PI, colonic c-kit mRNA expression was significantly decreased in infected 
C57BL/6 mice compared to non-infected controls (p unpaired t-test Welch’s correction = 
0.0037; Fig. 1B). MCP-1 and IL-10 mRNA expression was increased in infected C57BL/6 
mice, but did not remain significant after correction for multiple testing (Fig. 1B). At 14 days 
PI, there was a tendency towards increased IL-1β, IL-17 and IL-10 mRNA expression while c-
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kit mRNA expression was decreased in infected C57BL/6 mice, these results did not remain 
significant after correction for multiple testing (Fig. 1B). 
In contrast, infected Balb/c mice showed decreased colonic mRNA levels of MCP-1 and 
increased IL-10 mRNA expression compared to non-infected controls at 10 days PI (p 
unpaired t-test Welch’s correction < 0.004; Fig. 2B). IFN-ɣ, TNF-α, IL-1β and IL-17 mRNA 
were also upregulated, but could not withstand correction for multiple testing. At 14 days PI, 
TNF-α, IL-17 and IL-10 mRNA levels were increased (p unpaired t-test Welch’s correction 
<0.004, Fig. 2B). Of note, colonic mast cell tryptase a/b mRNA expression was increased at 
10 and 14 days PI in infected Balb/c mice, but could not withstand correction for multiple 
testing (Fig. 2B).   
Comparison of colonic inflammatory gene expression between infected C57BL/6 and Balb/c 
mice in the acute inflammatory phase revealed only increased tryptase a/b levels in Balb/c 
mice (unpaired t-test Welch’s correction p = 0.004) (Supplementary Fig. 2) and a tendency for 
increased IL-17 mRNA and decreased IL-6 in Balb/c mice, but this could not withstand 
correction for multiple testing. At 5 weeks PI, IFN-ɣ and IL-10 mRNA levels were 
significantly lower in infected Balb/c compared to infected C57BL/6 mice (Supplementary 
Fig. 2).  
H&E staining was performed to assess the degree of colitis using crypt length, crypt space 
and muscle thickness to address epithelial changes and overall mucosal architecture. 
Histology of the colon at 10 days PI shows signs of colitis as reflected by increased crypt 
length in both infected C57BL/6 (Fig. 3A) and Balb/c (Fig. 3B) mice compared to non-
infected controls (p unpaired t-test Welch’s correction = 0.029 and p <0.0001, respectively), 
an effect that was more pronounced at PI day 14 (Fig. 3A, B). No changes in muscle thickness 
or space between the crypts were observed between non-infected and infected mice, 
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irrespective of genetic immune background (data not shown). Based on the inflammatory cell 
infiltrate in mucosa and submucosa, mild hyperplasia and minimal goblet cell loss, we can 
conclude that C. rodentium induces a mild colonic inflammation in both mouse strains. 
At 5 weeks PI, in the absence of histological changes (Fig. 3A, B), infected C57BL/6 but not 
Balb/c mice still showed a tendency, albeit not statistically significant after multiple testing 
correction, towards increased colonic inflammatory mRNA expression of IL-1β, IL-6, IFN-γ 
and IL-17 compared to non-infected controls (Fig. 2B).  
Taken together, C. rodentium evokes a transient mild inflammatory response characterized by 
upregulation of inflammatory cytokine mRNA in both mouse strains at 10 and 14 days PI, 
with pronounced IL-17 mRNA upregulation.  
C. rodentium infection induces transient VHS in C57BL/6 and Balb/c mice  
Colorectal sensitivity was assessed by VMR at 2, 3 and 4 weeks PI and 24 hours post-WAS at 
5 weeks PI. At 2 weeks PI, in the presence of colonic inflammation, visceral sensitivity was 
significantly increased compared to baseline in both infected C57BL/6 (Fig. 4A) and Balb/c 
(Fig. 4B) mice. The response to colorectal distension (increase in visceral nociception at the 
maximum distension volume compared to pre-infection) was increased by 50 + 16% in 
C57BL/6 (p 2-wayANOVA=0.02) and by 143 + 31% in Balb/c (p 2-wayANOVA=0.03) 
mice. At 3 weeks PI, visceral sensitivity to colorectal distension returned to baseline levels in 
C57BL/6 mice, while the VMR response to colorectal distension was still significantly 
increased by 76 + 14% in Balb/c mice (p 2-wayANOVA=0.02). Only Balb/c mice with the 
highest VMR response at 2 weeks PI remained, to a lower extent, hypersensitive at 3 weeks 
PI (Supplementary Fig. 3). Visceral sensitivity normalized at 4 weeks PI in both mouse strains 
(Fig 4 A-D). 
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As stress may exacerbate or re-initiate visceral sensitivity
22, 38, 39
, we next assessed the effect 
of acute water avoidance stress (WAS) on post-infectious visceral sensitivity. One hour of 
WAS did not re-install VHS at 5 weeks PI (Fig. 4A-D). Visceral sensitivity to colorectal 
distension was similar to that before the infection, for both mouse strains (Fig. 4A-D).  
DISCUSSION 
In humans, it remains unclear why only a subgroup of infected individuals develops long-term 
PI-IBS. Based on the importance of mast cells in IBS symptom generation
25, 40-42
, we 
hypothesized that a Th2 immune background may increase the risk to develop PI-IBS and 
used Citrobacter rodentium as a murine model to study our hypothesis. In the present study, 
we evaluated the role of C. rodentium-induced inflammation and acute stress on visceral 
sensory function in Th1-predominant C57BL/6 and Th2-predominant Balb/c mice. C. 
rodentium induced a self-limiting colitis in both strains with induction of colonic 
inflammation and increased visceral sensitivity to colorectal distension at 2 weeks post-
infection. The increase in visceral nociception was transient and lasted 1 week longer in the 
Th2-predominant Balb/c mice. An episode of acute water avoidance stress (WAS) did not re-
initiate PI-VHS irrespective of the immunogenetic background. These results suggest that a 
Th2-predominant immunogenetic background may represent one of the risk factors to develop 
prolonged abnormal visceral nociception following an episode of infectious gastroenteritis. Of 
note, other strain-related factors, such as differences in nociception and behavior, may 
undoubtedly contribute as well.  
In mice, C. rodentium is known to induce an acute, self-limiting colitis, histologically 
associated with crypt hyperplasia and goblet cell depletion
43, 44
. The infection serves as a 
model for human infectious gastroenteritis induced by enteropathogenic Escherichia coli, a 
well-known trigger for PI-IBS in humans
45
. Upon infection, C. rodentium transiently 
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colonizes the distal colon with a peak of infection around 10 – 14 days PI in both C57BL/6
21
 
and Balb/c mice
46
. In line, we showed that C. rodentium induced a transient colonic 
inflammation, characterized by increased cytokine mRNA levels, irrespective of the genetic 
background, with overt inflammation at 14 days post-infection. The more pronounced colonic 
expression of IFN-ɣ/IL-17, identified as crucial players for host defense against infection
47
 at 
day 14 PI indicates that the peak of infection for both Th1 and Th2 predominant mice lays 
around 14 days post-infection. Inflammatory cytokine mRNA expression was however not 
significantly different between the two mouse strains, except for increased tryptase a/b 
mRNA levels in infected Balb/c mice compared to infected C57BL/6 mice. The peak of 
infection/inflammation was associated with an increase in visceral nociception to colorectal 
distension in both strains at 2 weeks PI. The duration of increased nociception differed 
however, i.e. Balb/c mice showed increased VMR responses to colorectal distension up to 3 
weeks PI (76% increase) while visceral perception of C57BL/6 mice was already normalized.  
Of interest, we noticed that mainly mice with a very high VMR response at 2 weeks PI (in 
particular Balb/c mice) remained VHS at 3 weeks PI (Supplementary Fig. 3), indicating that 
the magnitude of the VMR response at 2 weeks PI may be associated with a slower recovery 
and increased duration of the aberrant nociceptive response. One potential explanation may be 
the difference in immunogenetic background leading to more pronounced mast cell activation 
in the Th2 prone Balb/c mice, as suggested by increased tryptase a/b mRNA expression in the 
acute infectious phase in Balb/c mice compared to infected C57BL/6 mice. However, the 
degree of upregulation was relatively small questioning its physiological relevance. 
Moreover, Th2-associated cytokine expression did not differ between C. rodentium infected 
C57BL/6 and Balb/c mice, suggesting that other factors contribute to the prolonged VHS 
observed in infected Balb/c mice. In fact, there are indeed documented strain differences with 
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respect to behavioral
48, 49
 and nociceptive tests
50, 51
, most likely contributing to the prolonged 
VHS in Balb/c mice. It should also be emphasized though that the VHS observed in both 
strains completely normalized during the PI phase (i.e. at 4 weeks PI), while patients with PI-
IBS continue to have symptoms for several years following the infectious episode. These 
findings are in accordance with other studies, showing no increased VMR response in 
C57BL/6 mice 30 days PI
22
. Hence, other mechanisms may be critical for the development of 
chronic VHS. 
Psychological comorbidities such as stress, anxiety, depression and adverse early-life events 
are known to induce and/or exacerbate IBS symptoms
52-57
. Previously, van den Wijngaard et 
al.
58
 showed long-lasting VHS in response to an episode of acute stress, induced by water-
avoidance stress (WAS), in a rat model of maternal separation
58, 59
. Therefore, we evaluated if 
a previous gastrointestinal infection would increase the risk to develop VHS in response to 
WAS. In the present study however, acute WAS at 5 weeks PI did not recreate VHS, 
irrespective of genetic background. Our data therefore seem to indicate that stress applied 
after an intestinal infection is not a major trigger to develop long-lasting VHS. Indeed, 
Spreadbury et al.
60
 showed that chronic psychological stress after clearance of the infection 
did not have an additional effect on neuronal excitability compared to non-infected mice 
exposed to the same stressor
60
. Nevertheless, these data confirm that the bacterial infection 
per se does not alter visceral perception. It should be stressed though that psychological co-
morbidity prior to and not after clearance of the infection is associated with an increased risk 
to develop IBS
22, 60, 61
. In line, stress during or before C. rodentium infection results in an 
exaggerated peripheral nociceptive signaling compared to C. rodentium alone
22
 and to 
enhanced excitability of dorsal root ganglion neurons compared to non-infected controls
60
. 
Altogether, these data highlight the importance of the timing of stress relative to the infection. 
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This was indeed further corroborated by our recent study showing that psychological 
comorbidity prior to or during a gastrointestinal infection predisposes individuals to develop 
IBS. Of note, we showed that the type of immune response raised against the infection is 
associated with the risk to develop IBS. Patients who developed a Th2-predominant cytokine 
profile at the time of infection had an increased risk of PI-IBS 1 year later
62
. These data 
together with our current findings seem to support the hypothesis that the immunogenetic 
background may, at least to some extent, contribute to the risk to develop PI-IBS. 
Nevertheless, the duration of VHS in our murine PI model is rather short lasting, so clearly 
other factors must be involved.  
Of interest, recent evidence suggests that food allergens may be involved in IBS. Not only do 
more than 60% of patients with IBS report the onset or worsening of symptoms after meals
63
, 
submucosal instillation of food antigens in the duodenum was recently shown to evoke a local 
reaction with an instant influx of inflammatory cells and increased secretion
64
. Although the 
exact mechanism underlying these phenomena remains to be determined, one may speculate 
that an aberrant immune response to food antigens could be involved. Currently, we are 
investigating the hypothesis that prolonged VHS following a gastrointestinal infection may 
result from recurrent mast cell activation due to an aberrant immune response mounted 
against harmless intraluminal antigens present at the time of infection. If true, VHS will only 
develop upon re-exposure to these innocent bystander antigens, possibly explaining why no 
persistent VHS is observed in our current study. Preliminary data seem to support this 
hypothesis
65, 66
, but further experiments are clearly required.  
In summary, our study shows that C. rodentium infection induces a transient VHS in 
C57BL/6 and Balb/c mice, that is more pronounced and prolonged in Th2-predominant Balb/c 
mice. Although other strain-related differences, such as differences in nociception and 
behavior, may contribute, our data suggest that a Th2 background may represent an additional 
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risk factor for prolonged PI-VHS. It should be emphasized though that PI-VHS was transient 
and thus other factors must be involved in the persistent VHS as observed in patients with PI-
IBS. 
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TABLES  
Table 1 | Primer sequences for gene mRNA quantification by RT-qPCR.  
Gene Protein Forward primer (5’ -> 3’) Reverse primer (3’ –> 5’) 
Actb β-actin CATTGCTGACAGGATGCAGAA GCTGATCCACATCTGCTGGAA 
Il1b IL-1β GGGCCTCAAAGGAAAGAATC TACCAGTTGGGGAACTCTGC 
Il4 IL-4 AAGAACACCACAGAGAGTGAGCTC TTTCAGTGATGTGGACTTGGACTC 
Il6 IL-6 AAGTCGGAGGCTTAATTACACATGT CCATTGCACAACTCTTTTCTCATTC 
Il10 IL-10 AGAAGCATGGCCCTGAAATCAAGG CTTGTAGACACCTTGGTCTTGGAG 
Il13 IL-13 CACGGCCCCTTCTAATGAGG CCTCTCCCCAGCAAAGTCTG 
Il17 IL-17 ACCTCACACGAGGCACAAGT AGCAGCAACAGCATCAGAGA 
Ifng IFN-γ GCCATCAGCAACAACATAAGCGTC CCACTCGGATGAGCTCATTGAATG 
Tnf TNF-α CCCCAAAGGGATGAGAAGTT CACTTGGTGGTTTGCTACGA 
Ccl2 MCP-1 CCCCACTCACCTGCTGCTACT GGCATCACAGTCCGAGTCACA 
Kit c-kit TGGGAGCTCTTCTCCTTAGGAA TGCTCCGGGCTGACCAT 
Tpsb2 Tryptase β 2 GCAGCTAAGATGCTGAAGCG CCTCATGTCCTCCCACGATG 
Tpsab1 Tryptase α/β 1 TTGCTGACCCCAACAAGGTC GGACGATGTAGAAGTCGGGG 
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FIGURE LEGENDS 
Figure 1 | Effect of Citrobacter rodentium infection on body weight and inflammatory 
gene expression of infected C57BL/6 mice. A, Body weight change during 5 weeks 
following infection in C57BL/6 mice. Data are presented as mean ± SEM. 2-way ANOVA 
Bonferroni correction, * p < 0.05. B, Scatter plots of colonic inflammatory gene mRNA 
expression relative to β-actin in non-infected (non-inf, at 14d post-vehicle) and C. rodentium 
infected C57BL/6 mice at 10 days, 14 days PI and 5 weeks PI. n = 6 – 7 mice/group, unpaired 
t-test Welch’s correction, ** p < 0.004. The horizontal lines represent the mean ± SEM. d = 
day, IL = interleukin, IFN = interferon, MCP1 = monocyte chemotactic protein 1, non-inf = 
non-infected, PI = post-infection, TNF = tumor necrosis factor, w = week. 
 
Figure 2 | Effect of Citrobacter rodentium infection on body weight and inflammatory 
gene expression of infected Balb/c mice. A, Body weight change during 5 weeks following 
infection in Balb/c mice. Data are presented as m an ± SEM. 2-way ANOVA Bonferroni 
correction, * p < 0.05, ** p < 0.01. B, Scatter plots of colonic inflammatory gene mRNA 
expression relative to β-actin in non-infected (non-inf, at 14d post-vehicle) and C. rodentium 
infected Balb/c mice at 10 days, 14 days PI and 5 weeks PI. n = 6 – 7 mice/group, unpaired t-
test Welch’s correction, ** p < 0.004, *** p < 0.001. The horizontal lines represent the mean 
± SEM. d = day, IL = interleukin, IFN = interferon, MCP1 = monocyte chemotactic protein 1, 
non-inf = non-infected, PI = post-infection, TNF = tumor necrosis factor, w = week. 
 
Figure 3 | Acute C. rodentium infection induces mild colonic inflammation in both 
C57BL/6 and Balb/c mice. H&E staining showing colonic sections at 10x enlargement in 
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non-infected and C. rodentium infected C57BL/6 (A) and Balb/c (B) mice with associated 
crypt length measurements at day 10 PI, day 14 PI and at 5 weeks PI.  n = 4 – 7 mice/group. p 
unpaired t-test Welch’s correction as indicated. The horizontal lines represent the mean ± 
SEM. 
 
Figure 4 | Acute C. rodentium infection triggers transient VHS in both C57BL/6 and 
Balb/c mice that is not restored by acute water avoidance stress in the post-infectious 
phase. A-B Upper panel: VMR recordings in C57BL/6 (A) and Balb/c (B) mice measured 
before infection (pre-infection, black dotted line) and at 2 (blue full line) and 3 (orange full 
line) weeks PI. A-B Lower panel: VMR recordings measured at 4 weeks PI (grey full line) 
and at 5 (green full line) weeks PI following WAS.  n = 4 – 7 mice/group, 2-way ANOVA 
with Bonferroni correction, * p < 0.05, ** p < 0.01. Data are presented as mean + SEM.  
AUC of VMR responses measured throughout the whole experiment in C. rodentium infected 
C57BL/6 (C) and Balb/c (D) mice. The black horizontal lines represent the 95% percentile of 
the AUC of C. rodentium infected C57BL/6 and Balb/c mice measured prior to C. rodentium 
infection. Data are presented as mean ± SEM. p paired t-test, as indicated. AUC = area under 
the curve, hr = hour, PI = post-infection, pre-inf = pre-infection, VMR = visceromotor 
response, WAS = water avoidance stress, w = week. 
 
SUPPLEMENTARY FIGURES (for online publication only) 
Supplementary Fig. 1 | Acute C. rodentium infection induces subtle changes in 
inflammatory gene mRNA expression in the small intestine of C57BL/6 at 10 days post-
infection. Scatter plots of small intestinal inflammatory gene mRNA expression relative to β-
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actin in C57BL/6 (A) and Balb/c (B) mice at 10 days and 14 days PI. n = 6 – 7 mice/group, 
unpaired t-test Welch’s correction, *** p < 0.001. The horizontal lines represent the mean ± 
SEM. d = day, IL = interleukin, IFN = interferon, MCP1 = monocyte chemotactic protein 1, 
PI = post-infection, TNF = tumor necrosis factor. 
 
Supplementary Fig. 2 | Comparison of colonic inflammatory gene mRNA expression 
between C. rodentium infected C57BL/6 and Balb/c mice. Scatter plots of colonic 
inflammatory mRNA expression in non-infected and C. rodentium infected C57BL/6 and 
Balb/c mice at different time points (as indicated). n = 6 – 7 mice/group, unpaired t-test 
Welch’s correction, ** p < 0.004, *** p < 0.001. The horizontal lines represent the mean ± 
SEM. BL/6 = C57BL/6, d = day, IL = interleukin, IFN = interferon, MCP1 = monocyte 
chemotactic protein 1, non-inf = non-infected, w = week. 
 
Supplementary Fig. 3 | Maximum VMR response at 2 weeks post-infection correlates 
with duration of hypersensitivity. Individual data showing the AUC of VMR responses 
from C. rodentium infected C57BL/6 and Balb/c mice (as indicated) measured up to 4 weeks 
post-infection. n = 5 - 7 mice/group.  
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Dear Editor,  
We thank the reviewers for their comments and proposed suggestions. We have addressed all 
the issues raised and changed the manuscript accordingly. We are convinced that our revised 
manuscript has improved and hope it will be acceptable for publication in Neurogastro-
enterology & Motility.  
Yours sincerely,  
Mira Wouters 
Guy Boeckxstaens 
 
Reviewer 1 Comments: 
The authors provide a revised manuscript detailing the strain-dependent differences in visceral 
hypersensitivity following Citrobacter rodentium infection.  The single most important addition to 
the manuscript is the addition of data demonstrating changes in mast cell tryptase expression in the 
animals. These data support the importance of mast cells in visceral hypersensitivity, and provide the 
only evidence of a difference in immune responses that could explain differences in visceral 
hypersensitivity. The manuscript is greatly improved by this and the other changes. In light of these 
new data, the discussion could be more dramatically re-written, than what has been done. There 
remain only minor concerns with the manuscript. Also for the authors’ edification in response to 
their response to reviewer 1 comment #4, murine mast cells (as opposed to humans) contain TPH1 
that is important for immune function (Nowak et al., J Exp Med. 2012 209:2127). 
Reply: We thank the reviewer for his/her comments. As already indicated in our previous reply, the 
expression of TPH1 mRNA is very high compared to tryptase a/b (i.e. more than 10 cycles different or 
1024 fold increased), suggesting that TPH1 is not only expressed by mast cells but also by 
enterochromaffin cells, diluting the expression of mast cell-specific TPH1 and making it impossible to 
pick-up small differences in mast cell-specific TPH1. As proposed by the reviewer, we include here our 
TPH1 mRNA expression results in colonic tissue at various time points (see figure below). No 
significant differences for TPH1 mRNA levels were observed between non-infected and infected Balb/c 
mice, at any time point. However, for C57BL/6 mice, we found a significant decrease in TPH1 
expression at 14 days PI compared to non-infected controls. This drop may be due to colonic mucosal 
damage involving enterochromaffin cells and consequently decreasing TPH1 expression. Of note, the 
damage observed in C57BL/6 mice is more pronounced (p = 0.0007) than in infected Balb/c mice (p = 
0.0064) as shown in figure 3 of the manuscript. As TPH1 mRNA expression is not mast cell specific and 
the paper already contains many figures, we propose not to include this figure. Hopefully the reviewer 
can agree with our decision.  
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Minor concerns:  
1. Regarding original major concern #1, that the manuscript relies too heavily on strain dependent 
differences in immune responses rather than other potential strain-dependent differences, the 
authors have revised paragraph 3 of the discussion. Besides this paragraph, however, the 
discussion was not appreciably changed overall and the major conclusion remains that the TH2 
predominant background may be causative (see statements below). Given the data, these 
statements seem misleading to the reader and it is recommended that the overall tone of the 
discussion and abstract be changed.  Of particular interest, paragraph 1 of the discussion states 
“The increase in visceral nociception was transient and lasted longer in the Th2-predominant 
Balb/c mice.” Paragraph 4 of the discussion states “These data together with our current findings 
seem to support the hypothesis that the immunogenetic background may, at least to some 
extent, contribute to the risk to develop PI-IBS.” Paragraph 6 of the discussion (conclusion) states 
“In summary, our study shows that C. rodentium infection induces a transient VHS in C57BL/6 
and Balb/c mice, that is more pronounced and prolonged in Th2-predominant Balb/c mice, 
indicating that a Th2 immune background may increase the susceptibility to develop PIIBS.” 
Finally, the abstract states “Citrobacter rodentium infection induces transient VHS in C57BL/6 
and Balb/c mice, which is more pronounced and persisting in Balb/c mice, suggesting that a Th2 
background may represent a risk factor for prolonged PI-VHS.” 
 
Reply: We regret that the reviewer is not satisfied with our previous attempt to weaken our 
statements on the role of the immunogenetic background. We replaced “indicate” by “suggest” 
and included “may” in every statement, and provided alternative explanations for the observed 
difference between C57BL/6 and Balb/c mice. We agree that there are only minor changes in 
immunological parameters, but even in the food allergy model we routinely use in our lab (where 
mice sensitized to ovalbumin develop hypothermia, mast cell activation and diarrhea upon 
ovalbumin gavage), only minor changes can be detected using real time qPCR of intestinal tissue. 
In other words, it is a misconception to expect large changes in expression of Th2 cytokines. 
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Mainly based on our follow-up studies (showing failure of oral tolerance development and 
prolonged mast-cell mediated VHS in infected Balb/c but not in C57BL/6 mice) in the post-
infectious model used in the present manuscript (see reference 65 and 66 in the discussion at 
p.15), we feel confident that the Th2 background is a major determinant in the development of 
VHS. These data are however currently extended and cannot be included in the current paper. 
Nevertheless, we further weakened some of the statements cited above by the reviewer: 
 
1. Abstract: We added: “Although other strain-related differences may contribute, a Th2 
background may represent a risk factor for prolonged PI-VHS.” and we deleted the following 
sentence: “suggesting that a Th2 background may represent a risk factor for prolonged PI-
VHS”.  
2. Discussion first paragraph p. 12: We rephrased as follows: “These results suggest that a Th2-
predominant immunogenetic background may represent one of the risk factors to develop 
prolonged abnormal visceral nociception following an episode of infectious gastroenteritis. Of 
note, other strain-related factors, such as differences in nociception and behavior, may 
undoubtedly contribute as well.” and deleted the following statement: “This VHS is however 
transient, suggesting that other factors or triggers, resulting in a sustained abnormal pain 
response as observed in PI-IBS patients, must be involved.”  
3. Discussion last paragraph p.16: We deleted the following sentence: “indicating that a Th2 
immune background may increase the susceptibility to develop PI-IBS.” and we rephrased the 
last sentence into: “Although other strain-related differences, such as differences in 
nociception and behavior, may contribute, our data suggest that a Th2 background may 
represent an additional risk factor for prolonged PI-VHS. It should be emphasized though that 
PI-VHS was transient and thus other factors must be involved in the persistent VHS as 
observed in patients with PI-IBS. 
We hope the reviewer can accept this.  
2. The authors stated in response to the original minor concern (#10) that stress was not 
investigated at the three week time point when strain-dependent differences in hypersensitivity 
was observed, that “It is unclear why the reviewer would be interested to combine stress at this 
time point, especially as the aim of the study is to investigate strain-related differences in 
infection-induced VHS, and not in stress-induced differences.” If so, why was stress part of the 
experimental protocol at all? In the discussion, the authors state that a lack of stress-induced 
visceral hypersensitivity is not surprising because stress during or before, but not after infection 
is associated with visceral hypersensitivity. Again, the experiment does not seem to be framed 
well nor adequately discussed. If stress causes changes in sensitivity only during or before 
infection, should this rather than PI stage have been studied? 
 
Reply: We completely agree with the reviewer that a different set of experiments should have 
been performed to study the interaction between stress and infection, including experiments 
where stress is applied during or before the infection. These experiments have been reported 
previously by Ibeakama et al. and Spreadbury et al. indeed showing that stress applied before the 
infection rather than in the post-infectious phase increases the susceptibility to PI-VHS 
(Ibeakanma et al., 2009; Spreadbury et al., 2015) but this was only assessed in C57BL/6 mice and 
not in Balb/c mice. However, as the aim of our study was to investigate the role of the genetic 
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background and not the interaction between stress and infection as such, we hope the reviewer 
agrees that we decided not to perform these experiments. The only reason to add stress after the 
infection was to check if a previous infection, similar to maternal separation, could be a factor 
leading to increased susceptibility to develop stress-induced VHS. If the reviewer feels however we 
have to exclude these data, we are happy to do so. We already deleted the last sentence of the 
manuscript: “An acute episode of stress in the post-infectious phase could not re-introduce VHS 
indicating that other mechanisms leading to persistent VHS, as observed in patients, must be 
involved.”  
 
3. The second paragraph of page 15 remains speculative and outside of the range of the current 
manuscript. Food allergens are completely outside the aims of the current study and for the 
authors to state that they are currently working on this hypothesis seems inappropriate. If food 
allergens are so important, it begs the question why was stress used as a reinitiating factor, 
which the authors acknowledge is not expected to cause hypersensitivity at the time point they 
used, rather than food allergens.  I would recommend, again, deleting this paragraph. 
 
Reply: We agree that food allergens are completely outside the aim of the current study. 
However, in view of the largely negative findings on persistent or chronic VHS, we feel that 
speculation on potentially other explanations is part of an interesting discussion, and is of great 
interest for the reader to better position our data. We would therefore propose that the editor 
decides on keeping the paragraph about the food antigens in the discussion or not.  
 
4. There is no discussion regarding the apparent difference of no observable visceral 
hypersensitivity at 4 weeks in the current study and previous studies using C57Bl6 mice 
demonstrating enhance hyperexcitability of nociceptive DRG neurons at 30 days post-infection 
(Ibeakanma et al.). 
 
 Reply: We thank the reviewer for this comment. We have implemented this in the discussion in 
the first paragraph of p.14: “It should also be emphasized though that the VHS observed in both 
strains completely normalized during the PI phase (i.e. at 4 weeks PI), while patients with PI-IBS 
continue to have symptoms for several years following the infectious episode. These findings are 
in accordance with other studies, showing no increased VMR response in C57BL/6 mice 30 days 
PI
22
. Hence, other mechanisms may be critical for the development of chronic VHS.”     
 
Reviewer 2 Comments:  
Just one further grammatical comment page 15 line 22: Therefore, we checked if WAS could install 
prolonged VHS when applied in the post-infectious period. In the present study however, acute WAS 
at 5 weeks PI did not re-install VHS, irrespective of genetic background. "install" is a curious use of 
the word. I suggest: “Therefore, we checked if WAS could cause prolonged VHS when applied in the 
post-infectious period. In the present study however, acute WAS at 5 weeks PI did not recreate VHS, 
irrespective of genetic background”. 
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Reply: We have rephrased the first sentence and adjusted the comment as suggested (discussion 
p.14, 2
nd
 paragraph): “Therefore, we evaluated if a previous gastrointestinal infection would increase 
the risk to develop VHS in response to WAS. In the present study however, acute WAS at 5 weeks PI 
did not recreate VHS, irrespective of genetic background”. 
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